What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Cancer
Her main research concerns Internal medicine, Rheumatoid arthritis, Immunology, Rheumatology and Cell biology.
Her Internal medicine study combines topics in areas such as Gastroenterology, Placebo and Endocrinology.
Yoshiya Tanaka has researched Rheumatoid arthritis in several fields, including Methotrexate, Surgery, Arthritis, Infliximab and Rheumatism.
Her Surgery study incorporates themes from Adalimumab and Severity of illness.
Her Immunology study which covers Cancer research that intersects with Cancer cell, Synovial membrane, CD44, Synovitis and Apoptosis.
The concepts of her Cell biology study are interwoven with issues in Molecular biology, Integrin, Cell adhesion and Transfection.
Her most cited work include:
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (1096 citations)
- T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ (828 citations)
- Lymphocyte interactions with endothelial cells. (626 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Internal medicine, Rheumatoid arthritis, Immunology, In patient and Gastroenterology.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Surgery and Endocrinology.
Her work carried out in the field of Placebo brings together such families of science as Clinical endpoint and Randomized controlled trial.
Her Infliximab research extends to the thematically linked field of Surgery.
Her research in Rheumatoid arthritis intersects with topics in Physical therapy, Methotrexate and Arthritis.
Immune system, Antibody, B cell, Cytokine and Rituximab are among the areas of Immunology where the researcher is concentrating her efforts.
She most often published in these fields:
- Internal medicine (52.31%)
- Rheumatoid arthritis (36.83%)
- Immunology (22.26%)
What were the highlights of her more recent work (between 2019-2021)?
- Internal medicine (52.31%)
- Rheumatoid arthritis (36.83%)
- In patient (14.48%)
In recent papers she was focusing on the following fields of study:
Yoshiya Tanaka focuses on Internal medicine, Rheumatoid arthritis, In patient, Adverse effect and Gastroenterology.
Yoshiya Tanaka works mostly in the field of Internal medicine, limiting it down to topics relating to Placebo and, in certain cases, Randomized controlled trial and Clinical endpoint.
Her Rheumatoid arthritis research is multidisciplinary, incorporating elements of Discontinuation and Arthritis.
Her Adverse effect research incorporates elements of Incidence and Deep vein.
Her Gastroenterology research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Odds ratio and Receiver operating characteristic.
Her Clinical trial study integrates concerns from other disciplines, such as Certolizumab pegol, Anifrolumab and Immunology.
Between 2019 and 2021, her most popular works were:
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus (182 citations)
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial. (33 citations)
- Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials (22 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Her scientific interests lie mostly in Internal medicine, Rheumatoid arthritis, Clinical trial, Adverse effect and In patient.
Her Internal medicine research is multidisciplinary, relying on both Gastroenterology and Placebo.
Her Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Methotrexate, Disease, Antirheumatic drugs and Arthritis.
She focuses mostly in the field of Arthritis, narrowing it down to matters related to Tofacitinib and, in some cases, Visual analogue scale.
The Clinical trial study combines topics in areas such as Autoimmune disease, Anifrolumab, Immunology and Intensive care medicine.
Tuberculosis and Skin cancer is closely connected to Deep vein in her research, which is encompassed under the umbrella topic of Adverse effect.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
